Patent · US Expired

Variants of bovine pancreatic trypsin inhibitor and pharmaceutical use thereof

US5118668A · kind A · utility

54Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 1988
Grant dateJun 2, 1992
Priority date
Expiry dateJul 20, 2008

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptides having essentially the sequence of bovine pancreatic trypsin inhibitor (aprotinin) wherein one or more of the amino acids at positions 15, 16, 17, 18, 34, 39 and 52 are replaced by any naturally occurring amino acid produced by recombinant DNA technology, process, expression vector and recominant host therefor and pharmaceutical use thereof. Such peptides being useful as therapeutic agents in diseases connected with the presence of excessive amounts of proteinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.